387 related articles for article (PubMed ID: 10906625)
1. Pharmacology of ACE inhibitors versus AT1 blockers.
Vaughan D
Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
Johnston CI
Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive drugs and fibrinolytic function.
Fogari R; Zoppi A
Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X.
Feldman R
Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin-aldosterone system and fibrinolysis.
Felmeden DC; Lip GY
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):240-4. PubMed ID: 11881031
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
Sander GE; McKinnie JJ; Greenberg SS; Giles TD
Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
[TBL] [Abstract][Full Text] [Related]
10. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
Meyer P; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
[TBL] [Abstract][Full Text] [Related]
11. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Aulakh GK; Sodhi RK; Singh M
Life Sci; 2007 Aug; 81(8):615-39. PubMed ID: 17692338
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
Aihara E; Kagawa S; Hayashi M; Takeuchi K
J Physiol Pharmacol; 2005 Sep; 56(3):391-406. PubMed ID: 16204762
[TBL] [Abstract][Full Text] [Related]
14. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
Davie AP; Rumley A; Lowe GD; McMurray JJ
Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
[No Abstract] [Full Text] [Related]
16. [Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
Hauser AC; Hörl WH
Wien Med Wochenschr; 2001; 151(7-8):160-4. PubMed ID: 11450164
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
Soldner A; Spahn-Langguth H; Mutschler E
Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
[TBL] [Abstract][Full Text] [Related]
18. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system and cardiovascular disease.
Hollenberg NK
Blood Press Suppl; 2000; 1():5-8. PubMed ID: 11059628
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]